BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19597366)

  • 1. Neurohormonal regulation of cardiac ion channels in chronic heart failure.
    Kurokawa J; Abriel H
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):98-105. PubMed ID: 19597366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the survival benefit of neurohormonal antagonists in the management of geriatric congestive heart failure.
    Firdaus M; Bukhari N
    J Okla State Med Assoc; 2003 Mar; 96(3):133-9. PubMed ID: 12688226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic heart failure as a metabolic disorder.
    Anker SD; Al-Nasser FO
    Heart Fail Monit; 2000; 1(2):42-9. PubMed ID: 12634873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.
    Michael G; Xiao L; Qi XY; Dobrev D; Nattel S
    Cardiovasc Res; 2009 Feb; 81(3):491-9. PubMed ID: 18826964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurohormonal Regulation of I
    Shugg T; Hudmon A; Overholser BR
    J Am Heart Assoc; 2020 Sep; 9(18):e016900. PubMed ID: 32865116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.
    Dávila DF; Núñez TJ; Odreman R; de Dávila CA
    Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J
    Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal inhibition in heart failure: insights from recent clinical trials.
    Gheorghiade M; De Luca L; Bonow RO
    Am J Cardiol; 2005 Dec; 96(12A):3L-9L. PubMed ID: 16399087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
    [No Abstract]   [Full Text] [Related]  

  • 11. Two new culprits in cardiovascular disease: QT dispersion and aldosterone.
    Struthers AD
    J Hum Hypertens; 1995 Aug; 9(8):659-61. PubMed ID: 8523384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic heart failure (IV). The neurohormonal factors in chronic heart failure. Their clinical importance and therapeutic implications].
    Rayo I; Marín Huerta E
    Rev Esp Cardiol; 1991 Dec; 44(10):656-71. PubMed ID: 1686945
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic heart failure and sudden death: the message of CIBIS-III].
    Dequarti MC; Poggio L; Vanoli E
    Recenti Prog Med; 2007 Dec; 98(12):638-45. PubMed ID: 18369041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What causes sudden death in heart failure?
    Tomaselli GF; Zipes DP
    Circ Res; 2004 Oct; 95(8):754-63. PubMed ID: 15486322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P; Pott C; Eckardt L; Breithardt G
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamics in heart failure: implications for treatment.
    Rea ME; Dunlap ME
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):87-92. PubMed ID: 18090676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: ion channel remodeling in the failing ventricle.
    Nass RD; Aiba T; Tomaselli GF; Akar FG
    Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):196-207. PubMed ID: 18317475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal activation in the treatment of congestive heart failure: basis for new treatments?
    Pool PE
    Cardiology; 1998 Jul; 90(1):1-7. PubMed ID: 9693163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitivity in chronic heart failure.
    Ponikowski P; Banasiak W
    Heart Fail Monit; 2001; 1(4):126-31. PubMed ID: 12634897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.